LabPulse.com
  • Business Insights
  • Diagnostic Technologies
  • Diseases
  • Point-of-Care Testing
  • Research & Development
  • Sign In
  • About Us
  • Conferences
  • Videos
  • Webinars
  • Media & Press
Stay in the Know
Stay in the Know
Delivered right to your inbox, LabPulse’s newsletters keep you informed on the latest clinical lab updates. Subscribe to get exclusive access!
Business Insights
  • Policy & Regulation
  • Trends & Finance
Research & Development
  • Clinical Trials
  • Collaboration
  • Funding
Diagnostic Technologies
  • Clinical Chemistry
  • Emerging Technology
  • Immunoassays
  • Molecular Diagnostics
  • Pathology & AI
Diseases
  • Autoimmune
  • Cancer
  • Cardiovascular
  • COVID-19
  • Health Topics
  • Infectious
Resources
  • About Us
  • Conferences
  • Videos
  • Webinars
  • Media & Press
User Tools
  • Sign In
Follow LabPulse.com
Facebook iconTwitter iconLinkedIn icon
  • Business Insights
    • Policy & Regulation
    • Trends & Finance
  • Diagnostic Technologies
    • Clinical Chemistry
    • Emerging Technology
    • Immunoassays
    • Molecular Diagnostics
    • Pathology & AI
  • Diseases
    • Autoimmune
    • Cancer
    • Cardiovascular
    • COVID-19
    • Health Topics
    • Infectious
  • Point-of-Care Testing
  • Research & Development
    • Clinical Trials
    • Collaboration
    • Funding
  • About Us
  • Conferences
  • Videos
  • Webinars
  • Media & Press
  • Sign In
Follow LabPulse.com
Facebook iconTwitter iconLinkedIn icon

Top Story

3 D Prostate Cancer Viral Social
Prostate Cancer
In pilot study, liquid biopsy test differentiates between localized and metastatic cancer to inform tailored treatment
Cedars-Sinai Cancer researchers are developing a microfluidic device with a nanosurface as part of a blood test to inform treatment decisions.
Featured
Business Financial Results Social
Financial Results
Roche reports flat diagnostics revenue growth for 2022
Crispr Cas9 Gene Editing Social
Mergers & Acquisitions
Sherlock Biosciences acquires Sense Biodetection to drive CRISPR-based test adoption
Latest News
Nih Logo Social
Policy forum reviews NIH response to the COVID-19 pandemic
February 3, 2023
Scientists Pharmaceutical Laboratory Social
Siemens Healthineers, Unilabs ink 200-million euro agreement
February 2, 2023
Graph Financial Results Tablet Social
Quest Diagnostics Q4 revenues down 15% on COVID testing but base business grew
February 2, 2023
Covid 19 Financial Chart Social
Hologic fiscal Q1 diagnostics revenues drop 27% on lower demand for COVID testing
February 2, 2023
Business Insights
Graph Financial Results Tablet Social
Financial Results
Quest Diagnostics Q4 revenues down 15% on COVID testing but base business grew
Financial Results
Hologic fiscal Q1 diagnostics revenues drop 27% on lower demand for COVID testing
Financial Results
Roche reports flat diagnostics revenue growth for 2022
Collaboration
Genetic Technologies, Qiagen forming strategic alliance
View More »
Diagnostic Technologies
Scientists Pharmaceutical Laboratory Social
Collaboration
Siemens Healthineers, Unilabs ink 200-million euro agreement
Pathology and AI
3D spatial maps characterize biology enabling tumor growth: NIH director
Collaboration
Genetic Technologies, Qiagen forming strategic alliance
Artificial Intelligence
Guardant NSCLC biomarker test to incorporate Lunit’s AI-based scoring algorithm
View More »
Diseases
Graph Financial Results Tablet Social
Financial Results
Quest Diagnostics Q4 revenues down 15% on COVID testing but base business grew
Financial Results
Hologic fiscal Q1 diagnostics revenues drop 27% on lower demand for COVID testing
Sepsis
Sepsis increases heart failure, rehospitalization risks following hospital discharge
Cancer
Study suggests immune response to anticancer checkpoint inhibitors unaffected by COVID-19 vaccination
View More »
More from LabPulse.com
Sepsis increases heart failure, rehospitalization risks following hospital discharge
Hospital patients who initially had or developed sepsis were at higher risk for heart failure, rehospitalization, or death within 12 years than patients without sepsis.
February 1, 2023
Sepsis Bacteria Social
AstraZeneca, Capitainer to develop biomarker protocols using at-home patient sampling device
Capitainer's quantitative self-sampling product automatically separates cells from whole blood using a finger stick that can be done in a patient's home, potentially expanding access to individuals who would participate in clinical trials.
February 1, 2023
Clinical Trial Data Network Social
Study suggests immune response to anticancer checkpoint inhibitors unaffected by COVID-19 vaccination
Using an IgG ELISA kit and ELISPOT assay, the collaborators quantified immune responses in 41 people who were taking anti-PD-1/L1 checkpoint inhibitors to treat a range of cancers.
February 1, 2023
Vaccine Coronavirus Covid 19 Pixabay Social
3D spatial maps characterize biology enabling tumor growth: NIH director
In an NIH-sponsored study, researchers used cyclic immunofluorescence to obtain many rounds of highly detailed molecular imaging on each tissue sample and provided molecular data, cell by cell.
January 31, 2023
Lab Pathology Man Social
Genetic Technologies, Qiagen forming strategic alliance
Genetic Technologies said the alliance is expected to support the enhancement of its capabilities through software, hardware, consumable, and other technical solutions.
February 1, 2023
Sequencing Dna Rna Social
Beckman Coulter, MeMed collaborate to expand adoption of host immune response diagnostic test
MeMed developed its BV test to address the management of patients with acute infection in different clinical settings, including emergency departments, and distinguish between bacterial and viral infections early in the diagnostic process.
January 31, 2023
Sepsis Bacteria Social
Most Popular
Researchers find hidden bacteria that pose antimicrobial resistance risk to hospital patients
Quest Diagnostics Q4 revenues down 15% on COVID testing but base business grew
SD Biosensor, SJL Partners complete acquisition of Meridian Bioscience
OIG report outlines challenges with CDC-supported COVID-19 vaccination programs
Duke University developing blood test to detect osteoarthritis progression in the knee
Roche reports flat diagnostics revenue growth for 2022
More from LabPulse.com
Guardant NSCLC biomarker test to incorporate Lunit’s AI-based scoring algorithm
The integrated Lunit Scope PD-L1 algorithm will augment the TissueNext test’s detection of the PD-L1 biomarker in tissue samples using an AI-based scoring system.
February 1, 2023
Computer Ai Artificial Illustration Social
Jana Care, Roche to develop blood-testing platform for chronic kidney and heart disease
The platform would enable patients to self-administer critical blood tests at home, and allow clinicians to review the test results remotely.
January 31, 2023
Cardiac Heart Eeg Social
Duke University developing blood test to detect osteoarthritis progression in the knee
A new blood test may identify osteoarthritis progression in the knee more accurately than other methods, potentially advancing research and new therapies.
January 30, 2023
Knee Joint Pain Social
SD Biosensor, SJL Partners complete acquisition of Meridian Bioscience
The acquisition was agreed upon in July 2022 as an all-cash transaction valued at approximately $1.53 billion.
February 1, 2023
Business Deal Corporate Social
French point-of-care testing firm Biosynex to acquire Chembio Diagnostics for $17.2M
Each diagnostic company specializes in the development, manufacturing, and marketing of point-of-care diagnostic tests for the professional and at-home markets.
February 1, 2023
Hands Shaking Deal Social
California sisters plead guilty in $7.5M Medicare fraud involving phlebotomy services
They billed Medicare for medical services that were not reimbursable and overstated mileage for their traveling phlebotomists, according to the U.S. Attorney's Office for the Eastern District of California.
January 27, 2023
Gavel Money Social
LabPulse.com
Stay Connected
Delivered right to your inbox, LabPulse’s newsletters keep you informed on the latest clinical lab updates. Subscribe to get exclusive access!
Sign Up
Topics
  • Business Insights
  • Diagnostic Technologies
  • Diseases
  • Point-of-Care Testing
  • Research & Development
Resources
  • About Us
  • Conferences
  • Videos
  • Webinars
  • Media & Press
Follow LabPulse.com
Facebook iconTwitter iconLinkedIn icon
  1. Privacy Policy
  2. Contact Us
  3. Site Map
© 2023 Science and Medicine Group. All rights reserved.